KP Tissue has reported EBITDA of $31.7m compared to $29.3m a year earlier in its Q2 2013 results.
The Canadian tissue manufacturer released its results and those of Kruger Products (KPLP) reporting revenue of $246.8m compared to $231.3m in Q2 2012, an increase of 6.7% year on year.
Mario Gosselin, chief executive of KP Tissue and KPLP, said: “Our results for the second quarter were very solid, and we are particularly pleased that our EBITDA reached $31.7m.
“As we expected, our Canadian branded businesses reported higher sales when compared to the first quarter of 2013 due to a shift in promotional activities.”
The company increased its market share in all consumer product categories and Gosselin said that market acceptance of its TAD products “is as we have anticipated”.
The start-up phase of the company’s TAD facility is progressing as planned.
He added: “Margins have been somewhat impacted by rising commodity prices, fibre in particular, but these were not unforeseen… demand for our TAD products in the private label market in America is strong, and interest continues to build.”
However, he anticipated that higher commodity prices for pulp and energy will further impact the company’s third quarter results.